Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
Release Date:
Partner: Arvinas
Review Process: Pfizer Internal
Education Oncology All
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Oncology Japan
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
Release Date:
Partner: Bristol Myers Squibb
Review Process: Pfizer Internal
Education Internal Medicine All
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Rare Disease All
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Improving the care and outcomes of residents of Canada living with metastatic NSCLC
Release Date:
Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)
Release Date:
Partner: Crohn's & Colitis Foundation
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology USA
Improving the Equity and Quality of Cancer Care in Colombia
Release Date:
Partner: The Colombian Association of Oncology and Hematology (ACHO)
Review Process: Expert Review Panel
Translation: Spanish (link)
Quality Improvement Oncology Colombia
Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
Release Date:
Partner: The PROTEUS Consortium
Review Process: Expert Review Panel
Research Oncology USA
2024 Inflammatory Bowel Disease (IBD) Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditions
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Education Inflammation & Immunology Canada
Addressing Knowledge Gaps in Ulcerative Colitis (UC) Care
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA